晨光生物(300138.SZ)擬將棉籽板塊業務進行重組整合
格隆匯9月27日丨晨光生物(300138.SZ)公佈,公司第四屆董事會第二十四次會議審議通過了《關於<棉籽板塊重組整合方案>的議案》,根據公司戰略發展規劃,在不影響業務正常開展的前提下,擬將下屬棉籽板塊的業務及相關主體進行重組整合,以使單獨板塊業務架構更清晰,進一步提高經營管理效率,推動棉籽板塊業務更快更好發展,實現公司整體效益最大化。
本次棉籽板塊重組整合擬通過資產/負債劃轉(或股權劃轉)方式實施,重組整合完成後,晨光生物科技集團喀什有限公司將作為棉籽板塊各主體的母公司。
重組整合完成後,植物蛋白分公司根據公司經營管理需要繼續存續或註銷,不再經營棉籽類業務;圖木舒克晨光公司繼續做為公司的子公司存續,不再經營棉籽類業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.